1	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	3	NMOD	-1
2	and	and	I-NP	CC	O	3	NMOD	-1
3	IKK	IKK	I-NP	NN	B-protein	0	ROOT	-1
4	as	as	B-PP	IN	O	3	NMOD	-1
5	therapeutic	therapeutic	B-NP	JJ	O	6	NMOD	-1
6	targets	target	I-NP	NNS	O	4	PMOD	0
7	in	in	B-PP	IN	O	6	NMOD	-1
8	cancer	cancer	B-NP	NN	O	7	PMOD	-1
9	.	.	O	.	O	3	P	-1

1	The	The	B-NP	DT	O	3	NMOD	-1
2	transcription	transcription	I-NP	NN	B-protein	3	NMOD	0
3	factor	factor	I-NP	NN	I-protein	4	NMOD	-1
4	NF-kappaB	NF-kappaB	I-NP	NN	B-protein	8	NMOD	-1
5	and	and	O	CC	O	8	NMOD	-1
6	associated	associate	B-VP	VBN	O	8	NMOD	15	associated
7	regulatory	regulatory	B-NP	JJ	O	8	NMOD	-1
8	factors	factor	I-NP	NNS	O	21	SUB	-1
9	(	(	O	(	O	20	DEP	-1
10	including	include	B-PP	VBG	O	20	DEP	-1
11	IkappaB	IkappaB	B-NP	NN	B-protein	13	NMOD	-1
12	kinase	kinase	I-NP	NN	I-protein	13	NMOD	-1
13	subunits	subunit	I-NP	NNS	I-protein	19	NMOD	-1
14	and	and	O	CC	O	19	NMOD	-1
15	the	the	B-NP	DT	O	19	NMOD	-1
16	IkappaB	IkappaB	I-NP	NN	B-protein	19	NMOD	-1
17	family	family	I-NP	NN	I-protein	19	NMOD	-1
18	member	member	I-NP	NN	O	19	NMOD	-1
19	Bcl-3	Bcl-3	I-NP	NN	B-protein	10	PMOD	-1
20	)	)	O	)	O	8	NMOD	-1
21	are	be	B-VP	VBP	O	0	ROOT	-1
22	strongly	strongly	I-VP	RB	O	21	VMOD	-1
23	implicated	implicate	I-VP	VBN	O	21	VC	0
24	in	in	B-PP	IN	O	23	VMOD	-1
25	a	a	B-NP	DT	O	26	NMOD	-1
26	variety	variety	I-NP	NN	O	24	PMOD	-1
27	of	of	B-PP	IN	O	26	NMOD	-1
28	hematologic	hematologic	B-NP	JJ	O	30	AMOD	-1
29	and	and	I-NP	CC	O	30	AMOD	-1
30	solid	solid	I-NP	JJ	O	32	NMOD	-1
31	tumor	tumor	I-NP	NN	O	32	NMOD	-1
32	malignancies	malignancy	I-NP	NNS	O	27	PMOD	-1
33	.	.	O	.	O	21	P	-1

1	A	A	B-NP	DT	O	2	NMOD	-1
2	role	role	I-NP	NN	O	8	SUB	0
3	for	for	B-PP	IN	O	2	NMOD	-1
4	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	3	PMOD	-1
5	in	in	B-PP	IN	O	2	NMOD	-1
6	cancer	cancer	B-NP	NN	B-cell_type	7	NMOD	-1
7	cells	cell	I-NP	NNS	I-cell_type	5	PMOD	-1
8	appears	appear	B-VP	VBZ	O	0	ROOT	-1
9	to	to	I-VP	TO	O	10	VMOD	-1
10	involve	involve	I-VP	VB	O	8	VMOD	0
11	regulation	regulation	B-NP	NN	O	10	OBJ	16	regulation
12	of	of	B-PP	IN	O	11	NMOD	-1
13	cell	cell	B-NP	NN	O	14	NMOD	-1
14	proliferation	proliferation	I-NP	NN	O	12	PMOD	0
15	,	,	O	,	O	10	P	-1
16	control	control	B-NP	NN	O	15	ROOT	16	control
17	of	of	B-PP	IN	O	16	NMOD	-1
18	apoptosis	apoptosis	B-NP	NN	O	17	PMOD	5	apoptosis
19	,	,	O	,	O	20	P	-1
20	promotion	promotion	B-NP	NN	O	16	NMOD	17	promotion
21	of	of	B-PP	IN	O	20	NMOD	-1
22	angiogenesis	angiogenesis	B-NP	NN	O	21	PMOD	3	angiogenesis
23	,	,	O	,	O	20	NMOD	-1
24	and	and	O	CC	O	23	PMOD	-1
25	stimulation	stimulation	B-NP	NN	O	24	ROOT	17	stimulation
26	of	of	B-PP	IN	O	25	NMOD	-1
27	invasion/metastasis	invasion/metastasis	B-NP	NN	O	26	PMOD	14	metastasis
28	.	.	O	.	O	25	P	-1

1	Consistent	Consistent	B-ADJP	JJ	O	9	SUB	-1
2	with	with	B-PP	IN	O	1	AMOD	-1
3	a	a	B-NP	DT	O	4	NMOD	-1
4	role	role	I-NP	NN	O	2	PMOD	0
5	for	for	B-PP	IN	O	4	NMOD	-1
6	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	5	PMOD	-1
7	in	in	B-PP	IN	O	4	NMOD	-1
8	oncogenesis	oncogenesis	B-NP	NN	O	7	PMOD	-1
9	are	be	B-VP	VBP	O	0	ROOT	-1
10	observations	observation	B-NP	NNS	O	9	PRD	-1
11	that	that	B-SBAR	IN	O	10	NMOD	-1
12	inhibition	inhibition	B-NP	NN	O	22	SUB	18	inhibition
13	of	of	B-PP	IN	O	12	NMOD	-1
14	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	13	PMOD	-1
15	alone	alone	B-ADVP	RB	O	14	NMOD	-1
16	or	or	O	CC	O	13	PMOD	-1
17	in	in	B-PP	IN	O	13	PMOD	-1
18	combination	combination	B-NP	NN	O	17	PMOD	-1
19	with	with	B-PP	IN	O	18	NMOD	-1
20	cancer	cancer	B-NP	NN	O	21	NMOD	-1
21	therapies	therapy	I-NP	NNS	O	19	PMOD	19	therapies
22	leads	lead	B-VP	VBZ	O	11	SBAR	17	leads
23	to	to	B-PP	TO	O	22	VMOD	-1
24	tumor	tumor	B-NP	NN	O	26	NMOD	-1
25	cell	cell	I-NP	NN	O	26	NMOD	-1
26	death	death	I-NP	NN	O	29	NMOD	5	death
27	or	or	I-NP	CC	O	29	NMOD	-1
28	growth	growth	I-NP	NN	O	29	NMOD	4	growth
29	inhibition	inhibition	I-NP	NN	O	23	PMOD	18	inhibition
30	.	.	O	.	O	9	P	-1

1	However	However	B-ADVP	RB	O	6	VMOD	-1
2	,	,	O	,	O	6	P	-1
3	other	other	B-NP	JJ	O	5	NMOD	-1
4	experimental	experimental	I-NP	JJ	O	5	NMOD	-1
5	data	datum	I-NP	NNS	O	6	SUB	-1
6	indicate	indicate	B-VP	VBP	O	0	ROOT	-1
7	that	that	B-SBAR	IN	O	19	DEP	-1
8	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	9	SUB	-1
9	can	can	B-VP	MD	O	7	SBAR	-1
10	play	play	I-VP	VB	O	9	VC	18	play
11	a	a	B-NP	DT	O	14	NMOD	-1
12	tumor	tumor	I-NP	NN	O	14	NMOD	-1
13	suppressor	suppressor	I-NP	NN	O	14	NMOD	0
14	role	role	I-NP	NN	O	10	OBJ	0
15	in	in	B-PP	IN	O	10	VMOD	-1
16	certain	certain	B-NP	JJ	O	17	NMOD	-1
17	settings	setting	I-NP	NNS	O	15	PMOD	-1
18	and	and	O	CC	O	19	DEP	-1
19	that	that	B-SBAR	IN	O	6	VMOD	-1
20	it	it	B-NP	PRP	O	21	SUB	-1
21	can	can	B-VP	MD	O	19	SBAR	-1
22	be	be	I-VP	VB	O	21	VC	-1
23	important	important	B-ADJP	JJ	O	22	PRD	0
24	in	in	B-PP	IN	O	22	VMOD	-1
25	promoting	promote	B-VP	VBG	O	24	PMOD	0
26	an	an	B-NP	DT	O	28	NMOD	-1
27	apoptotic	apoptotic	I-NP	JJ	O	28	NMOD	-1
28	signal	signal	I-NP	NN	O	25	OBJ	-1
29	downstream	downstream	B-ADJP	JJ	O	28	NMOD	0
30	of	of	B-PP	IN	O	29	AMOD	-1
31	certain	certain	B-NP	JJ	O	34	NMOD	-1
32	cancer	cancer	I-NP	NN	O	34	NMOD	-1
33	therapy	therapy	I-NP	NN	O	34	NMOD	0
34	regimens	regimen	I-NP	NNS	O	30	PMOD	-1
35	.	.	O	.	O	6	P	-1

1	In	In	B-SBAR	IN	O	0	ROOT	-1
2	order	order	O	NN	O	1	DEP	-1
3	to	to	B-VP	TO	O	5	VMOD	-1
4	appropriately	appropriately	I-VP	RB	O	5	VMOD	-1
5	move	move	I-VP	VB	O	1	SBAR	0
6	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	7	NMOD	-1
7	inhibitors	inhibitor	I-NP	NNS	O	5	OBJ	-1
8	in	in	B-PP	IN	O	7	NMOD	-1
9	the	the	B-NP	DT	O	10	NMOD	-1
10	clinic	clinic	I-NP	NN	O	8	PMOD	-1
11	,	,	O	,	O	1	DEP	-1
12	thorough	thorough	B-ADVP	IN	O	11	VMOD	-1
13	approaches	approach	B-NP	NNS	O	14	SUB	-1
14	must	must	B-VP	MD	O	12	SBAR	-1
15	be	be	I-VP	VB	O	14	VC	-1
16	initiated	initiate	I-VP	VBN	O	15	VC	0
17	to	to	B-VP	TO	O	18	VMOD	-1
18	determine	determine	I-VP	VB	O	14	VMOD	-1
19	the	the	B-NP	DT	O	21	NMOD	-1
20	molecular	molecular	I-NP	JJ	O	21	NMOD	-1
21	mechanisms	mechanism	I-NP	NNS	O	18	OBJ	-1
22	that	that	B-NP	WDT	O	21	NMOD	-1
23	dictate	dictate	B-VP	VBP	O	22	SBAR	-1
24	the	the	B-NP	DT	O	25	NMOD	-1
25	complexity	complexity	I-NP	NN	O	23	OBJ	-1
26	of	of	B-PP	IN	O	25	NMOD	-1
27	oncologic	oncologic	B-NP	JJ	O	29	AMOD	-1
28	and	and	I-NP	CC	O	29	AMOD	-1
29	therapeutic	therapeutic	I-NP	JJ	O	30	NMOD	-1
30	outcomes	outcome	I-NP	NNS	O	26	PMOD	-1
31	that	that	B-NP	WDT	O	30	NMOD	-1
32	are	be	B-VP	VBP	O	31	SBAR	-1
33	controlled	control	I-VP	VBN	O	32	VC	0
34	by	by	B-PP	IN	O	33	VMOD	-1
35	NF-kappaB	NF-kappaB	B-NP	NN	B-protein	34	PMOD	-1
36	.	.	O	.	O	1	P	-1

